Stoll, Guido
Universitätsklinikum Würzburg,
Germany
2024 Rank: 117173
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 5151 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117173 | 109026 |
| Total Cites | 786 | 905 |
| H-index | 13 | 14 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 132 | 147 |
| Number of Single+First+Last Authored Papers | 137 | 137 |
| Total Cites to Single+First+Last Authored Papers | 285 | 325 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 645 | 684 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.32 |
| Self-Citation Percentage |
13.15%
|
|
Stoll, Guido
Universitätsklinikum Würzburg,
Germany
2023 Rank: 86602
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 4135 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86602 | 94315 |
| Total Cites | 837 | 984 |
| H-index | 13 | 13 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 165 | 178 |
| Number of Single+First+Last Authored Papers | 138 | 138 |
| Total Cites to Single+First+Last Authored Papers | 364 | 411 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 682 | 732 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.34 |
| Self-Citation Percentage |
14.94%
|
|
Stoll, Guido
Universitätsklinikum Würzburg,
Germany
2022 Rank: 78650
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 4105 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78650 | 76861 |
| Total Cites | 736 | 872 |
| H-index | 12 | 14 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 141 | 157 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 356 | 403 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 588 | 650 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.34 |
| Self-Citation Percentage |
15.60%
|
|
Stoll, Guido
Universitätsklinikum Würzburg,
Germany
2021 Rank: 76988
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 3994 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76988 | 73611 |
| Total Cites | 1064 | 1238 |
| H-index | 15 | 17 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 217 | 238 |
| Number of Single+First+Last Authored Papers | 130 | 130 |
| Total Cites to Single+First+Last Authored Papers | 485 | 541 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 853 | 924 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.34 |
| Self-Citation Percentage |
14.05%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.